recent host investor meet senior manag would remain
buyer share believ temporari medicaid headwind detract
fact ingeniorx compani primari long-term growth catalyst
track ahead expect believ risk/reward profil attract
adj ep estim
medicaid elig reverif greater expect impact
believ transitori headwind uncommon medicaid space
combin strong economi low unemploy result healthier
member often expans member trim medicaid roll
affect enrol much state financi standpoint
premium revenu declin due lower membership medic expens stay rel
flat low acuiti member els equal result higher
expect sequenti improv medicaid alreadi receiv rate
updat hand state help allevi pressur
state updat rate lag basi typic month suggest
us cost pressur could pose y/i headwind bit longer previous
anticip conserv increas estim bring
consolid full year project slightli midpoint compani
understand focu medicaid quarter think investor
would remiss ignor posit indic come ingeniorx transit
exist member onto ingeniorx progress smoothli compani
also secur first extern pbm client much earlier
suspect mani other street expect look believ
pois acceler growth across fulli insur self-fund book busi
result enhanc drug purchas econom ingeniorx annual save
enabl compani price competit within medicar believ
double-digit medicar advantag growth achiev near- medium-term
acceler growth pdp smaller opportun well improv pharmaci
cost structur also enabl compani gain share commerci fulli insur
book expect continu growth aso membership specialti penetr
compani refocus effort solid earli result target narrow
ebitda contribut aso fulli insur member
combin pharmaci specialti carve-in opportun well increas sale
clinic manag program estim could contribut annual earn
maintain outperform rate price target
adj ep estim remain unchang
respect lower ep estim rais
estim better reflect medicaid improv maintain
price target impli share trade adj ep estim
price target suggest upsid current level
pleas see page report import disclosur
much focu head center roll-out pbm ingeniorx
compani expect ingeniorx gener annual run-rat cost save
approxim worth ep accru sharehold fulli
transit compani acceler timelin ingeniorx termin
contract express script earli begin transit client
ingeniorx platform march vs previou expect januari earli
transit associ improv drug purchas econom estim worth
increment ep compani expect achiev full run-
rate save target end believ could posit compani
acceler commerci risk medicar advantag growth beyond
transit ingeniorx platform on-going
repres
bp y/i deterior medicaid
grow faster expect
lower expect cost save
delay associ ingeniorx
health benefit compani serv million medic member
decemb manag oper three segment commerci
specialti govern independ license cross
shield associ bcbsa associ independ health benefit plan offer
spectrum network-bas manag care plan larg small employ individu
medicaid senior market build pharmaci benefit manag
ingeniorx expect begin serv member may
believ entic buy opportun investor given estim
earn growth next year top among manag care peer attract valuat
share current trade adj ep estim compar group
averag believ focu temporari medicaid headwind
detract fact ingeniorx compani primari long-term growth catalyst
track ahead expect remaind believ focu
seamlessli transit exist member onto ingeniorx platform far
roll-out progress smoothli compani highlight minim disrupt
client issu resolv within hour day look expect
benefit ingeniorx drive addit growth antm medic membership particularli
medicar advantag compani enhanc drug purchas econom provid
competit tailwind year industry-wid headwind due return hif
medium-long term question around ingeniorx revenu growth whether
compani abl gain share highli concentr industri still first
inning earli return encourag obviou extern client target
plan recent pharmaci contract cross idaho
repres nice earli win remain seen whether ingeniorx succeed
blue non-blu health plan employ believ antm
medic membership base focu integr medical-pharmaci care model strong
brand recognit enabl compani win addit pbm busi extern
pbm growth like becom meaning part growth stori
one key issu earn medicaid elig reverif
much greater impact anticip market state elig
reverif caus near-term misalign rate other
receiv state acuiti medicaid member import note
lag rate updat fairli standard medicaid manag care compani would
point investor earli year mani compani over-earn rel
sustain long-term margin expans popul led state lower rate
appropri reflect member acuiti
current combin strong economi low unemploy result
healthier member often expans member trim medicaid roll
affect enrol much state state updat rate
lag basi typic month result lower revenu reduc
membership rel flat medic expens given acuiti popul els
equal net impact result higher posit alreadi secur
rate updat hand state allevi pressur
continu expect margin within long-term target rang albeit
lower end
go forward expect sequenti improv medicaid although
believ cost could remain elev quarter due delay time
state rate updat increas full year estim bp reflect
sustain cost pressur previous anticip full year
project slightli midpoint compani guidanc rang
quarterli analysi medic payabl vs premium growth ex-hif ex-pdp suggest
us compani suffici reserv
gener believ well posit medicaid busi compani
industry-lead win rate last five year recent reprocur
medicaid contract louisiana member march accord
state enrol report next major catalyst texa plu
contract expect award end august although would unsurpris
one contract award delay given state push
announc back sever time member chip
live texa
understand focu medicaid quarter think investor
would remiss ignor posit indic come ingeniorx especi given
import ingeniorx antm long-term strategi recent announc
cross idaho win big posit view ingeniorx abil win
extern busi key risk revenu growth target believ
cross idaho rel small piec busi total live accord
statutori file view solid earli win particularli consid ingeniorx still
process roll member
mention indic ingeniorx migrat process progress well
compani convert sever million member onto ingenio platform may
june transit anoth million juli receiv approv
commerci state medicaid state give us greater confid
non-medicar member success transit year-end medicar
aca-rel busi transit januari continu expect
earn contribut ingeniorx toward upper end
enhanc supplement benefit help drive meaning portion antm medicar
advantag growth januari compani note certain product
popular member expect antm bid like even
competit submit bid reflect better pharmaci econom believ
cost save ingeniorx provid competit advantag next year
rel competitor believ compani like better posit manag
hif headwind compani indic lead commerci
market share state lead medicar advantag market share one
state ohio abl achiev top market share ohio even though
plan believ competit pharmaci cost enabl
share gainer medicar market believ abil drive double-digit
membership growth near- medium-term achiev
histor under-penetrated group medicar advantag market
segment expect import compon compani growth stori
group medicar advantag member enter expect end
approxim cost benefit ingeniorx continu
drive strong growth compani target group medicar
advantag member compani contract two market ohio
new york neg affect hedi score compani expect
grow enrol market look updat whether compani
abl regain rate contract rate releas
also expect leverag ingeniorx drive growth medicar part area
busi smallest book rel peer
tradit focu area compani believ could look grow
busi go forward part medicar advantag member convers could also help
drive addit growth futur
posit increas specialty/pharmaci penetr stronger ebitda
emphas need acceler growth specialti product servic
compani deliv solid result current take five aso
member match ebitda contribut singl fulli insur member averag
target narrow profit gap combin
pharmaci specialti carve-in opportun well increas sale clinic
manag program assum compani abl grow specialti penetr
closer addit grow penetr pharmaci servic
estim could contribut annual earn growth compani grown
specialti enrol member compar growth
commerci growth histor benefit antm abil leverag
blue network strong nation market share enabl competit
unit cost compani less competit specialti product blue
nation network start chang follow antm build-out
nation network dental vision product went live
compani cite higher specialti penetr among self-fund client though
impact total enrol appear mute y/i basi given larg portion
tie individu membership exit year-end individu
membership abil offer custom nationwid network enabl
increas specialti penetr aso book dental vision penetr
current rang compani believ penetr rate approach
in-lin peer achiev
addit competit drug purchas econom launch ingeniorx
enabl improv pharmaci penetr rate well
commerci aso member compani indic harder win
medic membership pharmaci membership compani current
penetr aso book expect rate improv beyond
compani abl offer attract price believ employ increasingli
cogniz potenti long-term cost save integr medical-pharmaci
product employ continu shift fulli insur product aso
expect could continu gain share improv pharmaci specialti penetr
compani also expect ingeniorx drive market share gain within antm
commerci fulli insur group busi particular compani expect grow local
group specif small group membership sever year declin enrol
expect expand product offer better sale execut competit
price enabl ingeniorx enabl compani regain lost market share
estim membership loss last five year would worth annual
revenu suggest sizabl growth opportun importantli note march
investor day market share gain would come via heavili discount product
offer estim everi improv commerci market share gener
increment oper revenu
million except per-shar data
cowen compani estim
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
compani report cowen compani
fee expens expens ratio expens sg ex non-recur ratio ex non-recur tax add back hif-rel tax rate pre-tax hif-rel tax share o/ amort ep ex chang year-over-year premium sg ex non-recur ex non-recur end decemb cowen
million except per-shar data
compani report cowen compani
revenu premium fee expens expens ratio product product expens expens sg ex non-recur ratio ex non-recur oper tax add back hif-rel tax rate pre-tax hif-rel tax expens tax rate incom share o/ amort ep ex net incom chang year-over-year premium revenu cowen
million
cowen compani
assetscash cash term tax tax invest lend held current current assetsproperti equip intang term liabilitiesunpaid life accid polici policyhold accru tax trade pend portion long-term debt short-term lend held current current liabilitieslong-term debt benefits/reserv futur polici tax non-current equitycommon paid comprehens sharehold liabil sharehold liquid ratio current receiv claim payabl capit structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
oper activitiesnet gain net properti equip impair gain extinguish gain sale incom tax benefit share-bas loss discontinu oper asset polici liabilities/ medic unearn account payabl accru incom taxes- oper proce purchas secur asset proce repay debt acquisit /disposit netpurchas properti equip common stock dividend chang secur lend collater payabl net- non-curr begin net increas decreas end less cash cash equival discontinu op end year cash equival end yearfre year end decemb cowen
compani report cowen compani
oper activitiesnet gain impair gain extinguish sale incom net tax benefit share-bas loss discontinu properti oper asset invest polici liabilities/ medic unearn account payabl accru incom net oper invest activitiespurchas fix matur proce fix matur matur call purchas equiti proce sale equiti purchas invest proce sale invest settlement non-hedg chang secur lend purchas subsidiari net cash acquired- proce sale subsidiari net cash purchas properti proce sale properti net invest financ activitiesnet proce repay commerci proce long-term repay long-term proce short-term repay short-term chang secur lend chang bank premium paid equiti call options- proce sale put options- common stock proce issuanc common chang collater settlement debt-rel derivatives- dividend tax paid withhold common stock esp- excess tax benefit share-bas net financ net effect foreign begin net increas decreas end year end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
medicar market said believ insul given histor
blue aggress price would impact except
transit ingeniorx could take longer expect addit amount
compani believ gain save could come current estim
could turn impact amount expect revert sharehold
possibl transit time exce month could result higher cost
and/or delay realiz full save benefit improv pharmaci cost
